Sarepta will discontinue its next generation of exon-skipping drugs for Duchenne muscular dystrophy over safety concerns, in ...

Aptamer's Optimer technology achieves key milestones in genetic medicine delivery, enhancing targeting specificity and ...

SINGAPORE – Pharmaceutical giant AstraZeneca is set to create over 800 new skilled jobs here to staff a new manufacturing facility in Tuas South. The jobs range from engineering and technical services ...

Respiratory Inhaler Devices MarketThe global respiratory inhaler devices market, valued at USD 37,258.5 million in 2023, is projected to grow at a compound annual growth rate (CAGR) of 4.90%, reaching ...

Sir Mene Pangalos, Ph.D., joins Geoffrey von Maltzahn, Ph.D., Noubar Afeyan, Ph.D., Professor Sir Mike Stratton, and Michael Severino, M.D., on the board ...

AstraZeneca advances its ambition to redefine cancer care with new data across its industry-leading and diverse pipeline in hematology at the 66th American Society of Hematology (ASH) Annual Meeting ...

Pharmaceutical giant AstraZeneca said Thursday that the head of its China operations had been detained, after reports the ...

THE cut-off yield on Singapore’s latest six-month Treasury bill rose to 3.04 per cent, auction results released by the Monetary Authority of Singapore on Thursday (Nov 7) showed.

In part two of our showcase of six AI manufacturing lighthouses, hear what experts at AstraZeneca, Mengniu Dairy and Midea Group told the WEF ...

An influx of late-phase programs has prompted Genmab to reassess its bets. | An influx of late-phase programs has prompted Genmab to reassess its bets. The biotech is axing three early-stage clinical ...

Leon Wang, executive vice president in charge of China and the broader Asian region, is being detained while the Chinese ...